Tagged with UAE

Newbridge Pharmaceuticals Joe Henein, President & CEO of Newbridge Pharmaceuticals, talks about the evolution of the company since his joining, what makes Newbridge Pharmaceuticals a unique partner within the industry, and expounds on the many possible options for the future of the company. Newbridge Pharmaceuticals is a unique company within the Middle…

Abbvie Bassel Amer, Regional General Manager of Abbvie, discusses the company’s split in 2012, why it has been a good thing for both sides and everyone involved, including shareholders, and where he sees the Middle East market in the next five to ten years. On January 2012, Abbott split into two…

Abbvie Bassel Amer, Regional General Manager of Abbvie, discusses the company’s split in 2012, why it has been a good thing for both sides and everyone involved, including shareholders, and where he sees the Middle East market in the next five to ten years. On January 2012, Abbott split into two…

Medpharma Yanoof Al-Bidh, Vice Chairman and Managing Director of Medpharma, speaks about the core successes that the family-owned business has experienced thus far and what the next phase will look like for Medpharma. Medpharma is a family-owned company with its origins in Oman. What made you choose the UAE as the…

Collaboration Paolo Carli, Head of Middle East, KSA & Egypt for Merck Serono, speaks about the regions most pressing health issues—hypertension and diabetes— and how he thinks that collaboration of the industry with the government and educational institutes will help overcome this problem before it’s too late. What are some of…

UAE Samer Al Hallaq, Gulf President of AstraZeneca, speaks about the company’s strategy to align its portfolio with the increasing presence of lifestyle diseases like diabetes, and how innovation is the driving force behind continued growth for the future.   Let’s begin by speaking a little bit about AstraZeneca’s global focus…

Biotechnology Ashraf Allam, Regional Managing Director of Amgen, talks about the main challenges the company has faced, the benefit of building a company in the UAE, and the growth strategy of Amgen—past, present and future. Amgen is a relatively newcomer to the region having only established is operations in 2006. As…

UAE The two founders and managing partners of Genpharm talk about the market dynamics of the UAE, and the gaps in the market that the company was able to fill with its portfolio offering.    Karim, can you speak to us about the birth of Genpharm, and more broadly about your…

UAE Dr Ali Al Sayed, Director of the Pharmaceutical Services Department at the Dubai Health Authority and Chairman of DUPHAT Conference, speaks about the current endeavor of the Government to make the healthcare system in Dubai more accessible and cost-effective for everyone, how competition is healthy for the industry, and where…